FDA Grants PMA for Colorectal Cancer Mutation Test
A new molecular PCR test identifies KRAS mutations to aid in determining therapy for metastatic colorectal cancer.
Read MoreSearch Results for: lung cancer
Liquid Biopsies: Doing More with Less
An emerging method of molecular analysis holds significant potential for profiling the tumors where the biomarkers originated, and thereby improving the diagnosis and treatment of cancer and other diseases.
Read More
Inside Track: Molecular Markers for Colorectal Cancer
CLP speaks with Antonia R. Sepulveda, MD, PhD, FASCP, FCAP, of Columbia University, about a forthcoming clinical practice guideline for the use of molecular marker testing in patients with primary or metastatic colorectal carcinoma.
Read More
Pathology under Fire
Breast pathology experts share their views about a controversial JAMA study that has raised public anxiety and professional frustration.
Read More
Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study of Metastatic Lung Cancer
Noninvasive liquid biopsy enables detection of emerging T790M mutations with greater sensitivity than tissue biopsy and months before detection of cancer progression with imaging.
Read More